ConductScience.org, home

Paper14433

Prevention of pneumococcal pneumonia by vaccination.

Austrian R and 6 others. Trans Assoc Am Physicians, 1976. Cited by 235 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Prevention of pneumococcal pneumonia by vaccination. Papers, record 14433. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14433

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prevention of pneumococcal pneumonia by vaccination.
PubMed
Journal
Trans Assoc Am Physicians
PubMed
Year
1976
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
235
iCite
Relative citation ratio, by iCite
7.73
iCite
Revised in PubMed
2009-10-27
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Austrian RR
2Douglas RMR M
3Schiffman GG
4Coetzee AMA M
5Koornhof HJH J
6Hayden-Smith SS
7Reid RDR D

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bacterial VaccinesMajor topic
Pneumonia, PneumococcalMajor topic
VaccinationMajor topic
Antigens, Bacterial
Dose-Response Relationship, Drug
Humans
Sepsis
Streptococcus pneumoniae

Source PubMed

Cited by84

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 235 citations.

PMIDTitleJournalYearIn PapersSource
38,620,135[Guidelines for the management of community pneumonia in adult who needs hospitalization].Med Intensiva2005https://conductscience.org/library/papers/38620135PubMed
36,153,636The remarkable history of pneumococcal vaccination: an ongoing challenge.Pneumonia (Nathan)2022https://conductscience.org/library/papers/36153636PubMed
34,590,137Triumph of Pneumococcal Conjugate Vaccines: Overcoming a Common Foe.J Infect Dis2021https://conductscience.org/library/papers/34590137PubMed
34,019,468Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older.Hum Vaccin Immunother2021https://conductscience.org/library/papers/34019468PubMed
32,286,171How Basic Immunological Principles May Instruct the Design of a Successful HIV-Type 1 Vaccine.Viral Immunol2020https://conductscience.org/library/papers/32286171PubMed
30,700,048The Role of Serotype-Specific Immunological Memory in Pneumococcal Vaccination: Current Knowledge and Future Prospects.Vaccines (Basel)2019https://conductscience.org/library/papers/30700048PubMed
30,337,597Outpacing the pneumococcus: Antibody dynamics in the first few days following pneumococcal capsular antigen stimulation.Sci Rep2018https://conductscience.org/library/papers/30337597PubMed
29,261,406Effectiveness and practical uses of 23-valent pneumococcal polysaccharide vaccine in healthy and special populations.Hum Vaccin Immunother2018https://conductscience.org/library/papers/29261406PubMed
28,116,747Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.Cochrane Database Syst Rev2017https://conductscience.org/library/papers/28116747PubMed
28,061,505Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis.PLoS One2017https://conductscience.org/library/papers/28061505PubMed
27,009,210Pneumococcal Vaccination in High-Risk Individuals: Are We Doing It Right?Clin Vaccine Immunol2016https://conductscience.org/library/papers/27009210PubMed
27,002,793Vaccination of adults with 23-valent pneumococcal polysaccharide vaccine induces robust antibody responses against pneumococcal serotypes associated with serious clinical outcomes.Hum Vaccin Immunother2016https://conductscience.org/library/papers/27002793PubMed
24,925,139From empiricism to rational design: a personal perspective of the evolution of vaccine development.Nat Rev Immunol2014https://conductscience.org/library/papers/24925139PubMed
24,732,438Preventing non bacteremic pneumococcal pneumonia in older adults: historical background and considerations for choosing between PCV13 and PPV23.Hum Vaccin Immunother2014https://conductscience.org/library/papers/24732438PubMed
24,030,320Pneumococcal conjugate vaccination for older adults: Reply letter to Hollingsworth et al.Hum Vaccin Immunother2014https://conductscience.org/library/papers/24030320PubMed
23,732,892Pneumococcal vaccination of older adults: conjugate or polysaccharide?Hum Vaccin Immunother2013https://conductscience.org/library/papers/23732892PubMed
23,675,550Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.PLoS Negl Trop Dis2013https://conductscience.org/library/papers/23675550PubMed
23,440,780Vaccines for preventing pneumococcal infection in adults.Cochrane Database Syst Rev2013https://conductscience.org/library/papers/23440780PubMed
22,500,271Immune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination.Aging Dis2012https://conductscience.org/library/papers/22500271PubMed
21,963,800The development of vaccines: how the past led to the future.Nat Rev Microbiol2011https://conductscience.org/library/papers/21963800PubMed

See all 84 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14433

GET https://conductscience.org/api/papers/v1/14433/cited_by?page=2